Blood Collection Biorepository for Liver Disease Research

Recruiting now

Conditions studied: Non-Alcoholic Steatohepatitis(NASH), Hepatitis C, Hepatitis B, Fibrosis, Cirrhosis, Fatty Liver, Obesity, Childhood, Bariatric Surgery Candidate

In brief

The purpose of establishing a biorepository is to provide high quality specimens (serum, plasma, buffy coat and liver tissue) for future researchers who are studying the effects that fatty liver and viral diseases have on the liver.

Key facts

Study ID

NCT03025074

Run by

State University of New York at Buffalo

People needed

1000

Starts

2013-07-01

Expected to finish

2099-12-01

Last updated by the study team

2025-08-27

Who can join

Age: 7 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• This protocol is to establish a biobank of blood samples from individuals with or without liver diseases including viral hepatitis, liver cancer, NASH, and negative control samples.
• Children and teenagers will be special populations considered in this protocol.

You may not qualify if…

• Vulnerable populations such as adults unable to consent, infants, pregnant women or prisoners will not be considered for this research study.

Where it is running

• University at Buffalo, Buffalo General Medical Center — Buffalo, New York, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.